Editorial category Track F
Life sciences and biology
Vocabulary anchored in biological and life-sciences research disciplines.
- 17 August 2026
ORI Finds Research Misconduct by Former Baylor Nephrology Professor Liping Zhang
A 2025 ORI case summary found that Liping Zhang, PhD, a former Assistant Professor of Nephrology at Baylor College of Medicine, falsified and fabricated western blot and microscopy images across four NIH grant applications (NIDDK, NCI) and three unpublished manuscripts. Zhang did not contest the findings; ORI imposed a two-year debarment and PHS advisory-committee exclusion beginning January 16, 2025.
- 10 August 2026
Denisovans Interbred With Humans at Least Three Separate Times, Yale Study Finds
A Yale-led study reconstructed 832 million base pairs of Denisovan DNA from 177 Near Oceanian genomes, finding evidence of at least three distinct interbreeding events — and thousands of surviving variants still shaping immune response today.
- 10 August 2026
‘Foamy’ Microglia Emerge as a Driver of MS Progression, Study Finds
Lipid-laden ‘foamy’ microglia found in progressive MS lesions may drive disease progression, Dutch researchers report in Nature Neuroscience.
- 10 August 2026
Gut-to-brain: a vagus nerve pathway that shapes memory
A USC rat study in Nature Communications maps a gut-vagus-hippocampus circuit that supports memory after eating, and disrupts under early-life Western diet — work substantially funded by three stacked early-career fellowships (NIA, Quebec FRQS, Alzheimer’s Association) alongside the lab’s NIDDK grants.
- 10 August 2026
Georgetown Study: The Brain Can Rewire Itself for True Multitasking
Georgetown researchers find that with enough practice, learned tasks shift from the prefrontal cortex to the temporal cortex, letting the brain run two tasks in true parallel rather than rapidly switching between them.
- 10 August 2026
Antibody Targeting GPNMB Blocks Spread of Parkinson’s Pathology in Neurons
A Penn Medicine study in Neuron finds that GPNMB, an immune-related protein, helps spread Parkinson’s alpha-synuclein pathology between neurons — and that antibodies blocking GPNMB stopped that spread in lab studies. The paper credits specific NIH awards, including R01 NS115139 and P01 AG084497.
- 10 August 2026
Aging Protein EPS8 Identified as Trigger for ALS and Huntington’s Protein Clumping
A study from the University of Cologne’s CECAD Cluster of Excellence for Aging Research, published in Nature Aging, identifies EPS8 as an aging-linked protein whose rise with age triggers pathological protein aggregation in worm and human cell models of Huntington’s disease and ALS. Reducing EPS8 activity prevented the toxic aggregates and preserved nerve cell function, pointing to a candidate mechanistic link between cellular aging and neurodegenerative disease.
- 9 August 2026
CRISPR Tool Restores Immune Visibility in Prostate Cancer Cells
Duke and Rochester researchers used an RNA-editing CRISPR tool to block a shortening event in the SPSB1 gene’s mRNA, restoring MHC-I antigen display on prostate cancer cells and making tumors visible to the immune system in mouse models.
- 9 August 2026
mRNA Vaccines Get a T Cell Boost From Dendritic Cell ‘Cross-Dressing,’ WashU Study Finds
A WashU Medicine study published in Nature finds that mRNA-LNP vaccines prime CD8+ T cells largely through “cross-dressing” — dendritic cells, including cDC2 cells, picking up ready-made peptide-MHC-I complexes from other cells rather than processing antigen themselves. The mouse-model mechanism depends on type I interferon signaling and helps explain how mRNA vaccines generate robust killer T cell immunity.
- 9 August 2026
Montreal Team Finds a Third Immune Checkpoint T Cells Switch On Themselves
A Université de Montréal/IRCM team reports in Nature that SLAMF6, a receptor T cells trigger on themselves, acts as a third immune checkpoint distinct from PD-1 and CTLA-4 — a preclinical finding with CIHR funding that could open new combination approaches for checkpoint-inhibitor resistance.
- 9 August 2026
Dana-Farber Study Finds a Molecular Brake That Weakens Cancer Vaccines
A Dana-Farber-led study published in Science on July 9, 2026 identifies CARM1, an epigenetic enzyme, as a molecular brake on dendritic cells’ ability to present tumor antigens. Blocking it enhanced how well a cancer neoantigen vaccine primed T cells in preclinical models.
- 9 August 2026
CDK8 Inhibition Pushes Aggressive Pediatric Cancer Cells Toward Normal Muscle
Dana-Farber researchers show CDK8 inhibition slows tumor growth and pushes alveolar rhabdomyosarcoma cells toward normal muscle differentiation.
- 9 August 2026
A Backpack-Sized Field Lab Is Tracking Antimicrobial Resistance in Galápagos Wastewater
A Penn-led team built a backpack-portable microbiology lab to run on-site metagenomic sequencing in the Galápagos, tracking multidrug-resistant bacteria in wastewater-contaminated coastal waters without relying on cold-chain sample shipping.
- 9 August 2026
UVA Study Finds Just 36 Bacterial Species Across 352 Probiotics
A UVA-led study analyzed 352 probiotic products from major U.S. pharmacy chains and found only 36 unique bacterial species represented, highlighting a gap between commercial formulation and the mechanistic evidence for what each product claims to do.
- 9 August 2026
Reverse Ecology Reveals Hidden Lineages in the Gut Microbiome
A University of Vienna (CeMESS) team led by Martin F. Polz and Xiaoqian Annie Yu used a ‘reverse ecology’ approach to show that many gut bacterial species are actually several distinct evolutionary lineages, some linked to aging, IBD, colorectal cancer, and type 2 diabetes.
- 9 August 2026
Hungarian Team Identifies Gut-Phage ‘Molecular Anchor’ Mechanism With Therapeutic Potential
Researchers at HUN-REN Biological Research Centre, Szeged (Hungary) have identified surface adhesion proteins that act as ‘molecular anchors,’ letting certain gut bacteriophages bind human intestinal cells without infecting them. The finding, published in Nature Communications, points toward more precisely targeted phage therapies and new intracellular delivery strategies.
- 9 August 2026
Bacteriophages Unlock Vitamin B12 for the Gut Microbiome
A 2026 ISME Journal study from Virginia Tech shows bacteriophages that lyse vitamin-B12-producing gut bacteria release the vitamin at levels that reshape surrounding microbial communities — with NIH-funded data deposited in NCBI and Zenodo public repositories.
- 9 August 2026
Archaeal Cannulae, Solved: How Pyrodictium abyssi Self-Assembles Its Cell-Linking Filaments Without Chaperones
Two 2025 papers — one using cryo-EM, one using solution NMR — independently worked out how CanA, the building-block protein of the tubular “cannulae” filaments produced by the hyperthermophilic archaeon Pyrodictium abyssi, assembles into hollow fiber networks. The cryo-EM study shows calcium ions alone drive chaperone-free polymerization through a donor-strand-complementation mechanism; the NMR study resolves the monomer’s jellyroll fold and maps its ion-binding sites and polymerization kinetics. Cannulae have been observed since the 1980s connecting Pyrodictium cells into extensive networks, but their biological function is still not established.
